On May 21, 2026, ANI Pharmaceuticals Inc. held its Annual Meeting where stockholders approved the Amended 2022 Stock Incentive Plan and elected seven directors. The meeting had a quorum with 16,926,047 votes, and Ernst & Young LLP was ratified as the accounting firm for the fiscal year.